Thunderbeat features a new thermal shield designed to support safer procedures. The initial launch covers Japan. Olympus plans for a commercial launch in Europe, the U.S. and South Korea next month. Launches in other countries and regions are slated to follow.
Olympus’ Thunderbeat portfolio includes hybrid energy devices that deliver both ultrasonic and bipolar energy simultaneously. Uses include tissue management, such as hemostatic cutting and dissection, in laparoscopic surgery and open surgery. The company said the devices eliminate the need for multiple instruments during the surgery. This contributes to efficiency in the operating room and reduced operation time.
The company designed the new device for open surgical procedures that require delicate and fine tissue dissection, such as in thyroidectomy or radical neck dissection. The thermal shield improves the thermal profile on the grasping surface to reduce the risk of unintended heat damage. Its jaw maintains a finely curved tip for precise dissection and enhanced visibility.
Olympus said Thunderbeat offers the output of both bipolar and ultrasonic energy enables “a variety of operations.” It contributes to fast hemostatic cutting, easy dissection and reliable vessel sealing and division. The separate bipolar function enables vessel sealing and spot coagulation without cutting when desired.
“This latest addition to our differentiated Thunderbeat line of products continues to deliver on Olympus’ commitment to offering hospitals a full portfolio of Advanced Energy devices providing best-in-class functionality for numerous procedures and specialties in minimally invasive and open surgery,” said Phil Roy, global VP and GM of Olympus’ surgical devices business unit.
